Commitment Towards Precise Diagnostic Services: Metropolis Healthcare Launches New Greenfield Laboratoryin Panjab

Date:

Share post:

On 22nd May 2026, the Metropolis Healthcare, one of Indias leading diagnostics chain launches their new “Greenfield Laboratory” in Panjab’s Amritsar. The inauguration was graced by Dr. Anumeet Singh Grover, renowned gastroenterologist along with other renowned medical professionals across the country and leadership team from theMetropolis Healthcare.

The new facility is located at Main Majitha Road, one of Panjab’s prominent location. This facility is equipped with expertise across Biochemistry, Clinical Pathology, Immunoassay, and Haematology. It clearly indicates thecompany’s commitment towards delivering accurate, reliable, and timely diagnostic services not only in Punjab but also across this region. 

As a part of the Metropolis Healthcare’s “Greenfield and Acquisition” project pipeline, It is prioritizing states with geographic vacuums to extends its reach into unpenetrated markets by adding numerous greenfield labs and collection centres across domestic Tier-2 and Tier-3 cities alongside strategic acquisitions. The company has consistently invested heavily (e.g., up to ₹60–100 crore in dedicated capex) to establish new organic testing facilities.

This expansion in Panjab marks another step forward companies journey of empowering healthier lives through precision diagnostics and trusted healthcare solutions.

Written By Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...